Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice

INTRODUCTION: To evaluate stereotactic body radiotherapy (SBRT) in low-risk Prostate Cancer patients as preferred treatment option in emergency health conditions. MATERIALS AND METHODS: From April 2013 to September 2015, 28 patients with low-risk prostate cancer were prospectively enrolled. The SBRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Barra, Salvina, Guarnieri, Alessia, di Monale e Bastia, Michela Buglione, Marcenaro, Michela, Tornari, Elena, Belgioia, Liliana, Magrini, Stefano Maria, Ricardi, Umberto, Corvò, Renzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Radiobiology and Safety
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227177/
https://www.ncbi.nlm.nih.gov/pubmed/32415472
http://dx.doi.org/10.1007/s11547-020-01216-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227177/
https://www.ncbi.nlm.nih.gov/pubmed/32415472
http://dx.doi.org/10.1007/s11547-020-01216-9

Ejemplares similares